https://scholars.lib.ntu.edu.tw/handle/123456789/617770
標題: | A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer | 作者: | Kuemmel S. Campone M. Loirat D. Lopez R.L. Thaddeus Beck J. de Laurentiis M. Im S.-A. Kim S.-B. Kwong A. Steger G.G. Adelantado E.Z. Duhoux F.P. Greil R. Kuter I. YEN-SHEN LU Tibau A. ?zg?ro?lu M. Scholz C.W. Singer C.F. Vega E. Wimberger P. Zamagni C. Couillebault X.-M. Fan L. Guerreiro N. Mataraza J. Sand-Dejmek J. Chan A. |
公開日期: | 2022 | 出版社: | American Association for Cancer Research Inc. | 卷: | 28 | 期: | 1 | 起(迄)頁: | 106-115 | 來源出版物: | Clinical Cancer Research | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123388323&doi=10.1158%2f1078-0432.CCR-20-3955&partnerID=40&md5=4bc8ffa602ef63c2fef595ffc098f8dc https://scholars.lib.ntu.edu.tw/handle/123456789/617770 |
ISSN: | 1078-0432 | DOI: | 10.1158/1078-0432.CCR-20-3955 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。